克罗格于2024年10月4日完成其专业药房业务的出售，售价为4.64亿美元。此次出售使公司第三季度的总销售额比去年同期减少了大约3.4亿美元，预计未来年度销售将减少约30亿美元。KSP是一项低利润业务，其出售提高了克罗格的毛利率以及以销售为比率的经营、一般和管理成本，对营业利润没有实质性影响。
以上内容来自Benzinga Earnings专栏，原文如下：
Sale of Kroger Specialty Pharmacy
Kroger closed the sale of its specialty pharmacy business on October 4, 2024, for $464 million. The sale reduced total company sales in the third quarter by approximately $340 million, compared to the same period last year, and annualized sales will be approximately $3 billion lower going forward. KSP was a low margin business. As a result, the sale of the business increased both Kroger's gross margin and operating, general and administrative costs as a rate of sales. It had no material effect on operating profit.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.